PetMed Express, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Leslie C. G. Campbell
- Full Time Employees
- 189
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 420 South Congress Avenue Delray Beach FL United States of America 33445
- IPO Date
- Apr 26, 1999
- CIK
- 0001040130
- Website
- 1800petmeds.com
- Similar Companies
- Business
- PetMed Express, Inc. (PETS) operates as a leading online pet pharmacy in the United States, offering prescription and non-prescription medications, health products, food, supplements, and supplies for dogs, cats, and horses through its websites PetMeds.com and PetCareRx.com, mobile app, toll-free number, and direct mail. The company provides a comprehensive range of products including heartworm preventatives, flea and tick control, arthritis and joint care medications, thyroid and diabetes treatments, pain relief, blood pressure drugs, vitamins, nutritional supplements, hygiene items, pet foods, beds, crates, stairs, treats, and generic substitutes; it also maintains veterinary and pet insurance service partnerships. Founded in 1996 and headquartered in Delray Beach, Florida, PetMed Express serves consumers nationwide with over 15,000 stock-keeping units focused on affordable pet healthcare. In May 2025, the company announced a strategic partnership with telemedicine provider Dutch, enabling pet owners in 34 states to access licensed veterinarians via video for prescriptions directly fulfilled by PetMeds' inventory; it recently extended its shareholder rights plan in November 2025 and reported strategic updates to executive leadership.
PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash
PETS Q4 Earnings Call Focuses on Turnaround Foundation
PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates
PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
Broker sees vet business as hidden value driver at Pets at Home
Pets at Home rejigs shareholder returns as new CEO backs outlook
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
PetMed Express, Inc. Investigated by the Portnoy Law Firm
Head-To-Head Comparison: PetMed Express (NASDAQ:PETS) vs. RideNow Group (NASDAQ:RDNW)
PetMed Express (NASDAQ:PETS) Shares Cross Above Two Hundred Day Moving Average – What’s Next?
PetMed Express (NASDAQ:PETS) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
PetMed Express (NASDAQ:PETS) Shares Cross Above 200 Day Moving Average – What’s Next?
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
Newegg Commerce (NASDAQ:NEGG) vs. PetMed Express (NASDAQ:PETS) Head to Head Analysis
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS